<p><strong>What Is Sinusitis?</strong></p>
<p>Sinusitis is an inflammation, usually due to infection, of one or more of the four sets of sinus cavities within each side of the facial skeleton. When irritated, the mucous membrane lining the sinus may swell and block the small drainage channels that permit mucus to flow into the nose. The buildup in pressure often results in headache, nasal congestion, drainage and facial pain. Acute sinusitis is a common disorder that often follows a cold or flu; chronic sinusitis refers to persistent or recurrent episodes that are generally milder than acute cases. Sinusitis often subsides on its own and responds well to home treatment. Rarely, infection may spread to the eyes or brain, possibly leading to vision loss, meningitis, or brain abscess.</p>
<p><strong>Who Gets Sinusitis? </strong></p>
<p>Approximately 15% of people in the United States suffe...
Cavernous sinus thrombosis is treated with high-dose intravenous (through a vein) antibiotics. Sometimes surgery is needed to drain the infection.
Cavernous sinus thrombosis can be fatal. However, the death rate of this condition has improved tremendously since the introduction of antibiotics.
Calling your health care provider
Call your doctor right away if you have:
Bulging of your eyes
Inability to move your eye in any particular direction
“[Bisphosphonate] usage has been linked to the catastrophic condition ‘Dead Jaw.’ If you or a loved one have taken any of these drugs for osteoporosis… & you have experienced complications, you must act now! You may deserve compensation. For a free confidential case evaluation…” So reads the callout on a particular Web site devoted to “litigation regarding Bisphosphonate Complications.” Contrast that with this, from modernmedicine.com, “an online resource designed to meet the evolving needs of physicians,” November 15, 2008: “The last word on this controversy [the connection between bisphosphonate use and ONJ] has yet to be said, but according to a review of the literature by the American Society for Bone and Mineral Research, the risk of ONJ associated with oral bisphosphonate therapy for osteoporosis seems to be low, estimated between 1 in 10,000 and <1 in 100,000 patient treatment years.” ONJ. “Bi...
You should knowAnswers to your question are meant to provide general health information but should not replace medical advice you receive from a doctor. No answers should be viewed as a diagnosis or recommended treatment for a condition. Content posted by community members does not necessarily reflect the views of Remedy Health Media, which also reserves the right to remove material deemed inappropriate.